Clinical trials are scientific studies that involve people. Most clinical trials test how effective a new potential drug, medical device, or medical technique is at improving signs or symptoms of a particular condition OR prolonging the life of a patient with the condition. Clinical trials involve a strong collaboration between researchers, drug-makers/pharmaceutical companies, hospitals, patients, and doctors.
If you have questions about what is involved in a clinical trial, check out our clinical trial FAQ.
Ongoing Clinical Trials
There are several clinical trials in process right now that support research for GBS, CIDP, and variants. Please note that this information is intended to help patients be aware of all of their options; the Foundation is unable to endorse any clinical trials.
Clinical Trials for People Currently Experiencing CIDP
-
Pediatric CIDP Patients for a Clinical Research Study
Has Your Child been diagnosed with CIDP? Octapharma is seeking Pediatric patients for a clinical research study (NGAM-11) to access two different IVIg doses in the treatment of CIDP For US Audience Only Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where the body’s natural defenses, like antibodies, attack the covering of the nerves,…
-
Vitalize, CIDP Clinical Trial – For US Audience Only
VITALIZE (EFC18156) For US Audience Only A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (VITALIZE) The purpose of the study is to evaluate effects and safety of riliprubart compared to IVIg in adult participants with CIDP who…
-
Mobilize Clinical Trial for CIDP – For US Audience Only
Mobilize Clinical Trial for CIDP For US Audience Only MOBILIZE (EFC17236) A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work (MOBILIZE) The purpose of this Phase 3 study is to test the effects and safety of riliprubart compared…
-
CIDP ARISE Clinical Trial
Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication. Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where thebody’s natural defenses, like antibodies, attack the covering of the nerves, called myelin,and damage nerve function. While symptoms aren’t the same for everyone, CIDP canmake your…
Clinical Trials for People Currently Experiencing GBS
-
International Guillain-Barré Syndrome Outcome Study (IGOS) Clinical Trial
International Guillain-Barré Syndrome Outcome Study (IGOS) The international GBS Outcome Study (IGOS) is the largest and longest prospective trial designed to collect extensive data from patients afflicted with GBS in a systematic manner. The aim is to collect information from patients by intensive international collaboration. All patients are followed at standard intervals from the earliest…
Clinical Trials for People Currently Experiencing MMN
-
Empassion Study for MMN
A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Empasiprubart Versus Intravenous Immunoglobulin in Adults with Multifocal Motor Neuropathy A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults with Multifocal Motor Neuropathy (Empassion) The main purpose of this study is to compare empasiprubart and IVIg in…
-
ARDA Multifocal Motor Neuropathy Study Clinical Trial
ARDA Multifocal Motor Neuropathy Study – This study is completed and no longer recruiting patients The ARDA study is designed to assess the safety and effectiveness of the investigational study drug compared to a placebo for the treatment of adults living with MMN. Participants enrolled in the study will be randomly assigned by a computer…
